Lawmakers object to provision seeking to prevent brand-name and generic drug manufacturers from agreeing to settlements that essentially trade cash for promises that generic drug firms will not challenge brand-name drug patents for a set period of time.
OVERSIGHT - ALL ARTICLES
Industry officials, analysts argue that government pays more when work is performed in-house.
House and Senate Armed Services committees are unlikely to experience upheaval in leadership approach regardless of the November election results.
The GOP has sought to make spending and the deficit an election issue.
Measures clear the panel along party lines, with Republicans withholding support amid concerns about discretionary spending levels.
Bill targets workers who willfully avoid payments, but employee groups say it could end up punishing people trying to do the right thing.
The strain on military families does not end when the troops return from Iraq or Afghanistan.
Bipartisan group of former officials ask Justice Department to publicly oppose Calif. ballot initiative legalizing pot.
Elizabeth Warren will serve as an assistant to the president and special adviser to Treasury secretary.
Some of the recommendations in a highly critical Senate report are off-base, Defense IG says.